Efficacy of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with High-Risk Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the L-Mind Study
Year: 2020
Type: article
Source: Blood
Institutions: Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Duran i Reynals Hospital, Universitat de Barcelona, University of Würzburg, Universitätsklinikum Würzburg, University of Turin, Universitat Autònoma de Barcelona, Josep Carreras Leukaemia Research Institute, Hospital Universitari Germans Trias i Pujol, Semmelweis University, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Clinica Universidad de Navarra, Paracelsus Medizinische Privatuniversität, MorphoSys (Germany), The Ohio State University Wexner Medical Center, The Ohio State University, University of Liverpool, Université de Lyon, Hospices Civils de Lyon
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097558747